Foreword

Beneficial Microbes

Volumn 4, Issue 1, 2013, Pages 1-2

  Venema, Koen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

OLIGOSACCHARIDE; PREBIOTIC AGENT; PROBIOTIC AGENT;

BACTERIAL OVERGROWTH; BACTERIAL STRAIN; BENEFICIAL ORGANISM; BREAST MILK; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DRUG EFFECT; EDITORIAL; GENETIC STABILITY; HUMAN; INTESTINE FLORA; LACTOBACILLUS; MICROFLORA; NONHUMAN; NUTRIENT CONTENT; OBESITY; ANIMAL; JOURNAL IMPACT FACTOR; PUBLICATION; PUBLISHING;

ANIMALS; EDITORIAL POLICIES; HUMANS; JOURNAL IMPACT FACTOR; PERIODICALS AS TOPIC; PREBIOTICS; PROBIOTICS;

EID: 84875271399     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2013.x001     Document Type: Editorial

References (18)

1. Agito, M.D., Atreja, A. and Rizk, M.K., 2013. Fecal microbiota transplantation for recurrent C. difficile infection: Ready for prime time? Cleveland Clinic Journal of Medicine 80: 101-108.
2. Brandtzaeg, P., 2013. Gate-keeper function of the intestinal epithelium. Beneficial Microbes 4: 67-82.
3. Enos, M.K., Burton, J.P., Dols, J., Buhulata, S., Changalucha, J. and Reid, G., 2013. Probiotics and nutrients for the first 1000 days of life in the developing world. Beneficial Microbes 4: 3-16.
4. Hell, M., Bernhofer, C., Stalzer, P., Kern, J.M. and Claassen, E., 2013. Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic. Beneficial Microbes 4: 39-51.
5. Hoffmann, D.E., 2013. Health claim regulation of probiotics in the USA and the EU: is there a middle way? Beneficial Microbes 4: 109-115.
6. Jeurink, P.V., Van Bergenhenegouwen, J., Jiménez, E., Knippels, L.M.J., Fernández, L., Garssen, J., Knol, J., Rodríguez, J.M. and Martín, R., 2013. Human milk: a source of more life than we imagine. Beneficial Microbes 4: 17-30.
7. Lahtinen, S.J., Davis, E. and Ouwehand, A.C., 2012. Lactobacillus species causing obesity in humans: where is the evidence? Beneficial Microbes 3: 171-174.
8. Meijerink, M., Mercenier, A. and Wells, J.M., 2013. Challenges in translational research on probiotic lactobacilli: from in vitro assays to clinical trials. Beneficial Microbes 4: 83-100.
9. Petrof, E.O., Claud, E.C., Gloor, G.B. and Allen-Vercoe, E., 2013. Microbial ecosystems therapeutics: a new paradigm in medicine? Beneficial Microbes 4: 53-65.
10. Rijkers, G.T., Bimmel, D., Grevers, D., Den Haan, N. and Hristova, Y., 2013. Consumer perception of beneficial effects of probiotics for human health. Beneficial Microbes 4: 117-121.
11. Rothe, M. and Blaut, M., 2013. Evolution of the gut microbiota and the influence of diet. Beneficial Microbes 4: 31-37.
12. Sanders, M.E., Heimbach, J.T., Pot, B., Tancredi, D.J., Lenoir-Wijnkoop, I., Lähteenmäki-Uutela, A., Gueimonde, M. and Bañares, S., 2011. Health claims substantiation for probiotic and prebiotic products. Gut Microbes 2: 127-133.
13. Schultz, M., Baranchi, A., Thurston, L., Yu, Y.C., Wang, L., Chen, J., Sapsford, M., Chung, J., Binsadiq, M., Craig, L., Wilkins, B., McBride, D. and Herbison, P., 2011. Consumer demographics and expectations of probiotic therapy in New Zealand: results of a large telephone survey. New Zealand Medical Journal 124: 36-43.
14. Sybesma, W., Molenaar, D., Van Ijcken, W., Venema, K. and Kort, R., 2013. Genome instability in Lactobacillus rhamnosus GG. Applied Environmental Microbiology, in press.
15. Tsilingiri, K. and Rescigno, M., 2013. Postbiotics: what else? Beneficial Microbes 4: 101-107.
16. Van Loveren, H., Sanz, Y. and Salminen, S., 2012. Health claims in Europe: probiotics and prebiotics as case examples. Annual Review of Food Science and Technology 3: 247-261.
17. Venema, K., 2012. Foreword. Beneficial Microbes 3: 1-2.
18. Von Ossowski, I., Reunanen, J., Satokari, R., Vesterlund, S., Kankainen, M., Huhtinen, H., Tynkkynen, S., Salminen, S., De Vos, W.M., Palva, A., 2010. Mucosal adhesion properties of the probiotic Lactobacillus rhamnosus GG SpaCBA and SpaFED pilin subunits. Applied Environmental Microbiology 76: 2049-2057.